Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
87.3M
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
1.92M
-
Shares change
-
+73.7K
-
Total reported value, excl. options
-
$15.2M
-
Value change
-
+$582K
-
Put/Call ratio
-
1.05
-
Number of buys
-
13
-
Number of sells
-
-6
-
Price
-
$7.91
Significant Holders of Immunome Inc. - COMMON STOCK (IMNM) as of Q2 2023
38 filings reported holding IMNM - Immunome Inc. - COMMON STOCK as of Q2 2023.
Immunome Inc. - COMMON STOCK (IMNM) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.92M shares
of 87.3M outstanding shares and own 2.2% of the company stock.
Largest 10 shareholders include Point72 Asset Management, L.P. (418K shares), VANGUARD GROUP INC (374K shares), Alpine Global Management, LLC (366K shares), Prentice Capital Management, LP (112K shares), BANK OF MONTREAL /CAN/ (100K shares), GEODE CAPITAL MANAGEMENT, LLC (81.2K shares), Cerity Partners LLC (67.1K shares), MILLENNIUM MANAGEMENT LLC (66K shares), RENAISSANCE TECHNOLOGIES LLC (44.5K shares), and BlackRock Inc. (43.3K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.